SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VERISANTE TECHNOLOGY
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: croman10/10/2011 6:17:05 PM
   of 254
 
MELA VS VERISANTE

There are some significant differences between the Verisante Aura, and the MelaFind in terms of design, effectiveness and market potential.
-The Verisante Aura uses an advanced laser scanning system to identify 21 different biochemical markers in the skin, enabling the device to detect all types of Skin Cancer in under a second.
-Mela uses a computerized imaging technology which compares a lesion to thousands of images in a data base but the results take a few minutes.
-The MelaFind only screens for Melanoma while the Verisante Aura is able to identify all types of Skin Cancer and is much faster. Melanoma only represents 4% of Skin Cancer so Mela appears to be missing out on the other 96% of the market.
- Verisante is already underway with clinical studies for the early detection of lung and colon cancer, demonstrating the company’s commitment to development of revolutionary technology for early cancer detection, and creating a pipeline of future products to market.

Device sensitivity is a crucial clinical consideration.
-The Verisante Aura has demonstrated 98% sensitivity and 78% specificity for Melanoma while the MelaFind demonstrated 98% sensitivity but only 9.5% specificity for the detection of Melanoma. Too many false positives represent a key clinical concern and are why the FDA recommended approval by a very narrow margin for Mela.

Device design is also a big consideration.
-Verisante has a very sleek modern design to their system, consisting of small handheld device attached to a console that can easily be moved around.
-The Verisante Aura has a tiny probe that can access lesions all over the body.
- The system also uses inexpensive disposable tip covers representing another source of revenue.
-MelaFind has a very large probe and will be more difficult to access lesions in some areas. The probe also requires some preparation to the skin’s surface.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News